Uthever® Sponsored Studies

As a clinically-backed anti-aging ingredient brand, Uthever® takes pride
in supporting cutting-edge research that explores the vast potential of our products.


Uthever® Empowers Health Beyond Anti-Ageing

Through our sponsored studies, we delve into the versatile applications of Uthever®, unlocking its efficacy not only in the area of anti-ageing but also aiding in mitigating various diseases and promoting overall health. Our commitment to scientific exploration enables us to showcase the true power of Uthever® and its positive impact on different health conditions.

Unlock the Power of Uthever® Now

Discover the transformative results of Uthever® through rigorous scientific investigations, and join us in the journey towards a brighter, healthier future.

Learn more

Information on Uthever® Patents, Clinical Studies and Trials

Uthever® Patents

Our parent company, EffePharm, has recently filed a new PCT patent for Uthever® NMN. This patent application pertains to the use of NMN in the preparation of a reagent designed to increase the levels of Na+-K+-ATPase in damaged skin muscle membranes.

Research conducted through UVB-induced mouse skin injury experiments yielded results. It demonstrates that NMN can increase the activity of Na+-K+-ATPase in the skin and has the potential to reduce inflammatory damage, providing a foundation for potential treatments or supplements focused on addressing skin aging, skin damage, and antioxidant support.

This patent exemplifies our commitment to advancing human health and anti-ageing efforts, aiming to make the benefits of Uthever® NMN accessible to a wider audience.

Pioneering NMN Clinical Studies

EffePharm, as the first NMN Manufacturer to conduct NMN clinical trials, has made significant strides in the field of NMN research. Amidst the extensive body of research primarily focused on animal studies, EffePharm took a pioneering step by conducting our proprietary clinical study on Uthever® NMN which is registered in the US under the ID NCT04228640 NMN.

The meticulously designed trial, titled “Evaluate the Efficacy and Safety of Uthever® NMN (Nicotinamide Mononucleotide, a Form of Vitamin B3),” published in Frontiers in Ageing, employed a multi-center, randomized, double-blind, parallel design, and placebo-controlled approach to ensure the collection of reliable and valid data for assessing NMN’s potential benefits.

Key findings from this clinical trial reveal a significant increase in NAD+/NADH levels in the serum, indicating NMN’s capacity to elevate cellular NAD+ levels. This increase is associated with heightened energy levels and anti-ageing effects. Notably, participants using Uthever® experienced improvements in walking capacity and overall well-being.

Furthermore, the study assessed insulin sensitivity, revealing promising indications of potential anti-ageing effects, as the placebo group exhibited worsened parameters. Most importantly, this trial also confirmed NMN’s safety and tolerability, even at dosages of up to 300 mg.

Notable NMN Research

Uthever® NMN has shown results in mitigating radiation-induced intestinal damage through its ability to modulate gut microbiota and enhance NRF2 levels. These studies demonstrate that NMN supplementation could succeed in counteracting the negative impact of radiotherapy and thereby enhance its potential as a viable and effective treatment for cancer. Clinical studies are called for to further verify that the same benefits of NMN supplementation apply to human cancer patients, highlighting the potential for NMN to play a crucial role in cancer treatment.

EffePharm’s research into NMN’s potential applications extends beyond cancer treatment. NMN has showcased potential across a spectrum of research areas such as improving skin conditions like Atopic Dermatitis, mitigating the impact of COVID-19 on lung health, and much more.

EffePharm’s Ongoing Commitment to NMN Research and Innovation

Our pursuit of scientific excellence has driven us to conduct more clinical trials and research, reaffirming our commitment to providing safe and effective NMN products for a healthier future. Visit our website to stay up to that on the latest Uthever® NMN news.